Yiping H. Zhang
1 Banshan East Road
Hangzhou, 310022, China
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 173 publications
Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16A.
Journal: Molecules (Basel, Switzerland)
Published: April 06, 2026
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026
Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial.
Journal: The Lancet. Oncology
Published: January 22, 2026
Association between feeding pattern before age 2 years and preschool children's diet quality
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: January 21, 2026
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2025
Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial.
Journal: The Lancet. Respiratory medicine
Published: October 19, 2025
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 09, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2025
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer.
Journal: Translational lung cancer research
Published: June 03, 2025
International guidelines on the diagnosis and treatment of NUT carcinoma.
Journal: Innovation (Cambridge (Mass.))
Published: April 11, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.
Journal: Cancer biology & medicine
Published: April 09, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study.
Journal: Cell reports. Medicine
Published: December 18, 2024
Last Updated: 09/26/2026